A Paleolithic-type diet may help obese postmenopausal women lose weight, improve their circulating fatty acid profile and lower their future risk for diabetes and cardiovascular disease, new research reports. The study results will be presented in a poster Sunday, April 3, at ENDO 2016, the annual meeting of the Endocrine Society, in Boston.
New findings from large-scale studies of more than 3.6 million people who underwent screening for cardiovascular disease reveals that a person’s age and gender affects the prevalence of certain types of peripheral vascular diseases (PVD), and that diabetes is a major risk factor for developing these diseases, even in patients without heart disease.
A new study from Intermountain Medical Center Heart Institute and Johns Hopkins Medical Center lends more evidence to the idea that it’s better to be shaped like a pear — with weight around the hips — as opposed to an apple — with weight around the abdomen.
Loyola Medicine is enrolling patients in a landmark clinical trial of a new procedure to treat atrial fibrillation, in which a physician uses a tiny lasso to tie off a thumb-size pouch attached to the heart.
End-stage heart failure patients treated with stem cells harvested from their own bone marrow experienced 37 percent fewer cardiac events - including deaths and heart failure hospital admissions - than a placebo-controlled group, according to a new study. Results from ixCELL-DCM, the largest cell therapy clinical trial for treating heart failure to date, will be presented at the 2016 American College of Cardiology annual meeting and published online in The Lancet on April 4.
A Saint Louis University scientist, Jane McHowat, Ph.D., will study how smoking impacts cardiac health beyond injury to the body’s arteries by damaging the heart muscle itself.
The Cardiovascular Research Foundation (CRF) announced today that Daniel Burkhoff, MD, PhD, has returned to the organization as Director of Heart Failure, Hemodynamics and Circulatory Support in the CRF Clinical Trials Center (CTC).
Patients undergoing minimally invasive mitral valve repair or replacement (mini-MVR) have similar outcomes as patients undergoing conventional surgery and also experience shorter hospital stays and fewer blood transfusions
Cerebral cavernous malformations (CCMs) are clusters of dilated, thin-walled blood vessels in the brain that can cause stroke and seizures, yet exactly how they form is somewhat of a mystery. Now, researchers have discovered the molecular mechanism that underlies this common cerebrovascular disease.
PinnacleHealth CardioVascular Institute enrolled the first two patients in the United States in a randomized trial studying a heart valve to treat aortic valve disorders.
To understand how people can live longer throughout the world, researchers at University of California, San Diego School of Medicine have teamed up with colleagues at University of Rome La Sapienza to study a group of 300 citizens, all over 100 years old, living in a remote Italian village nestled between the ocean and mountains on the country’s coast.
Physicians and fellows from the Cardiovascular Research Foundation (CRF) will be presenting abstracts at the American College of Cardiology 65th Annual Scientific Session taking place April 2-4, 2016 at McCormick Place in Chicago, IL. They will be sharing the latest data on drug-eluting stents, imaging technologies, dual antiplatelet therapy, transcatheter aortic valve replacement, and bioresorbable vascular scaffolds.
According to the World Health Organization, 37 million people are living with HIV. Antiviral medications are used to control the disease and prevent its progression to AIDS. Although antivirals improve health and increase survival for people with HIV, their use also has been linked to the development of cardiovascular disease. Now, researchers at the University of Missouri School of Medicine have identified an enzyme that may reduce the risk of cardiovascular disease caused by HIV medications.
Nearly 1 million people in the United States receive coronary artery stents each year. Nearly all stent patients are expected to take dual antiplatelet therapy (DAPT) using the combination of aspirin and a second antiplatelet medication to prevent the formation of blood clots. Exactly how long patients should receive DAPT has been debatable.
Building on its national reputation in both cardiac research and women’s health, NYU Langone Medical Center has received nearly $4 million in a four-year research grant from the American Heart Association (AHA) and has been selected as a center in the AHA’s new Go Red For Women Research Network.
Despite messages to the contrary, most women being seen by a doctor for the first time with suspected heart disease actually experience the same classic symptoms as men, notably chest pain and shortness of breath, according to a study led by the Duke Clinical Research Institute.
Patients recovering from heart attacks or other heart trouble could cut their risk of another heart incident by half if they incorporate stress management into their treatment, according to research from Duke Health.
The Cardiovascular Research Foundation (CRF) is excited to announce the launch of TCTMD’s new podcast network, the Pulse of Cardiology. TCTMD is the leading online resource for cutting-edge news and information in interventional cardiovascular medicine, and beyond.
PinnacleHealth CardioVascular Institute enrolled the first patient in Pennsylvania into the TOBA II clinical on October 19, 2015. This trial is to assess the safety and efficacy of a vascular implant for the treatment of dissections (tearing in the artery wall) that occur following balloon angioplasty (PTA) of the main artery in the leg.
New research has provided more evidence that an innovative treatment strategy may help prevent brain swelling and death in stroke patients. J. Marc Simard, professor of neurosurgery at the University of Maryland School of Medicine, along with colleagues at Yale University and Massachusetts General Hospital, found that Cirara, an investigational drug, powerfully reduced brain swelling and death in patients who had suffered a type of large stroke called malignant infarction, which normally carries a high mortality rate.
Ming-Hui Zou has received a four-year, $1.9 million grant from the National Heart, Lung, and Blood Institute, a division of the National Institutes of Health (NIH), to fight cardiovascular disease.
Just published in the Journal of Pediatrics, a long-term study initiated by the Children’s Hospital of Michigan DMC shows how more severe cases of pediatric cardiomyopathy-linked heart disease are associated with reduced “quality of life and functional status,” which can have a negative impact on families of the patients and thus contribute to poor outcomes.
Nearly half of all atrial fibrillation (AF) patients at the highest risk for stroke are not being prescribed blood thinners by their cardiologists, according to a new study by researchers at University of California, San Diego School of Medicine and University of California, San Francisco.
Could an unhealthy diet and lack of exercise be making you age faster? Researchers at Mayo Clinic believe there is a link between these modifiable lifestyle factors and the biological processes of aging. In a recent study, researchers demonstrated that a poor diet and lack of exercise accelerated the onset of cellular senescence and, in turn, age-related conditions in mice. Results appear today in Diabetes.
A surgical team at Baylor University Medical Center at Dallas successfully performed a heart transplant on a patient living with a total artificial heart (TAH), a first time event in North Texas. The lifesaving TAH technology, a portable device that pumps blood throughout the body, is used as a "bridge" until a donor heart becomes available.
Ensuring the health and safety of student athletes is a priority at Texas A&M, especially in the Department of Health and Kinesiology and the Health Science Center College of Medicine. Recent research sheds light on the healthy cardiac parameters and blood pressure levels of collegiate athletes.
Obesity, which is associated with low-grade inflammation, is an important contributor in the development of diabetes and cardiovascular disease. While the role of several organs including adipose tissue have been implicated in this process, the cell types and factors driving this process have not been clear. Using a pre-clinical model of obesity, researchers at Brigham and Women's Hospital (BWH) have discovered that a small, non-coding RNA molecule called miR-181b is an important determinant of obesity-induced changes in adipose tissue by controlling the function of the vessels in adipose tissue.
Adults living with congenital heart disease may have a significantly higher risk of post-traumatic stress disorder (PTSD) than people in the general population. Clinicians and caregivers may need to be aware of possible PTSD symptoms, such as anxiety and depression, in their patients.
The Valley Hospital in Ridgewood, NJ, is one of 15 U.S. sites currently enrolling patients in a research study to evaluate a potential new treatment alternative for patients with symptomatic persistent and long standing persistent atrial fibrillation (AFib).
The generally accepted medical maxim that elevated HDL cholesterol is “good” has been overturned by a multi-center, international study, They show that a certain genetic cause of increased HDL-C may actually be “bad,” noting that a specific mutation in a gene which encodes a cell receptor protein that binds to HDL prevents the receptor from functioning. It causes an increased risk of heart disease even in the presence of elevated levels of “good” cholesterol.
A 10-year follow-up study of more than 6,000 people who underwent heart CT scans suggests that a high coronary artery calcium score puts people at greater risk not only for heart and vascular disease but also for cancer, chronic kidney disease and chronic obstructive pulmonary disease (COPD).
Given the high stress levels, extended periods of screen time and regular social outings many Americans experience day-to-day in environments where high-calorie foods are readily available, it can be easy to fall into the habit of mindless eating – where we’re too distracted to pay attention to how much, what and why we’re eating. Research suggests that practicing mindfulness – or taking the time to bring awareness to present-moment experiences with an open attitude of curiosity and non-judgment – can be effective in allowing us to make more thoughtful food choices and recognize when we are hungry, satisfied or full. The latest research in this area led by Jennifer Daubenmier, PhD, Assistant Professor at the Osher Center for Integrative Medicine at the University of California, San Francisco, suggests that the impact of mindful eating could be even greater.
BOSTON – While the protective connection between moderate alcohol consumption and heart health has been well-studied, new research from Beth Israel Deaconess Medical Center (BIDMC) and the Harvard T. H. Chan School of Public Health suggests that the association is more complicated than is widely accepted. Researchers found that in the hour following even moderate consumption of alcohol, the risk of heart and stroke doubled.
Working long hours—particularly 46 hours per week or more—may increase the long-term risk of cardiovascular disease (CVD) events such as heart attack, reports a study in the March Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine (ACOEM).
When Michael Hess, M.D., started VCU Massey Cancer Center's Cardio-Oncology Program three years ago, it was the first in the state and one of only a handful in the country. Since then, the program has grown exponentially and is still the only one in Richmond dedicated to protecting the hearts of patients undergoing cancer treatment.
A new study from Washington University School of Medicine in St. Louis has identified two genes that, when altered in specific ways, either promote or undermine cardiovascular health. The findings may help guide efforts to design new preventive drugs, similar to the way statins now are prescribed to lower “bad” cholesterol to reduce the risk of heart disease.
Cardiac stem cells could be an effective treatment for a common but difficult-to-treat type of heart failure, a new study from the Cedars-Sinai Heart Institute shows. The study, embargoed until Feb. 29 at 2 p.m. ET, has led to clearance by the U.S. Food and Drug Administration (FDA) for an Investigational New Drug (IND) application to test the cells in patients.
A popular smartphone app purported to accurately measure blood pressure simply by placing a cellphone on the chest with a finger over the built-in camera lens misses high blood pressure in eight out of 10 patients, potentially putting users’ health at risk, according to research from Johns Hopkins.
With apps and activity trackers measuring every step people take, morsel they eat, and each symptom or pain, patients commonly arrive at doctor's offices armed with self-tracked data. Yet health care providers lack the capacity or tools to review five years of Fitbit logs or instantaneously interpret the deluge of data patients have been collecting about themselves, according to new University of Washington research.
Andrew DeFilippis, M.D., M.Sc., will study archived blood samples from thousands of patients to determine whether the presence of certain lipids in a person’s bloodstream can be used to pinpoint women at risk for having a heart attack.
At 31, Somerset resident Shawn Fohs was the picture of good health: fit, with no chronic health conditions, and a reputation of never getting sick. But on Aug. 2, an undiagnosed heart condition nearly cost Fohs his life. Using cardiac ablation, a Rutgers cardiac electrophysiologist helped resolve the underlying problem and save his life.
Fetal interventionists and pediatric cardiologists perform an “in utero atrial septal stent procedure” to open the atrium, allowing blood trapped in the lungs and left upper heart chamber of a HLHS fetus to flow back to the right side of the heart. The successful procedure was a first for the CHLA-USC Institute for Maternal-Fetal Health and a first for a Southern California hospital.
A 59-year-old heart patient with dangerously high levels of cholesterol that could not be adequately reduced by statin drugs now has near-normal cholesterol levels, thanks to a new class of drugs that grew out of work done by UT Southwestern Medical Center researchers.